Efficacy and Safety of Tocilizumab for Coronavirus Disease 2019 (Covid-19) Patients: A Systematic Review and Meta-analysis
Conclusion Our study does not support the routine use of tocilizumab
for COVID-19 patients. Future studies should focus more on other potential
therapies for COVID-19 patients. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Drug Research - Category: Drugs & Pharmacology Authors: Hariyanto, Timotius Ivan Hardyson, Willie Kurniawan, Andree Tags: Original Article Source Type: research
More News: Actemra | Coronavirus | COVID-19 | Databases & Libraries | Drugs & Pharmacology | Statistics | Study